Sandoz Omeprazol 20 mg

Sandoz Omeprazol is a widely used generic medication belonging to the proton pump inhibitor (PPI) category, designed to treat conditions like acid reflux and stomach ulcers. The Sandoz brand has a rich history dating back to 1886 in Basel, Switzerland, when it was founded by Alfred Kern and Edouard Sandoz. For decades, it operated as a major global pharmaceutical player before merging with Ciba-Geigy in 1996 to form Novartis.

After serving as the generics division of Novartis for twenty years, Sandoz was spun off as a fully independent, publicly-traded company in October 2023. Today, the Sandoz Group AG is headquartered in Basel, Switzerland, and is a global leader in generic and biosimilar medicines. This specific product is manufactured in Spain, primarily through specialized facilities like Laboratorio Liconsa, S.A. in Guadalajara, under the local oversight of Sandoz Farmacéutica, S.A. based in Madrid.